BAM Capital as of Dec. 31, 2010
Portfolio Holdings for BAM Capital
BAM Capital holds 73 positions in its portfolio as reported in the December 2010 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
InterMune | 9.5 | $96M | 2.6M | 36.40 | |
Dendreon Corporation | 7.9 | $80M | 2.3M | 34.92 | |
Cree | 7.5 | $76M | 1.2M | 65.89 | |
Boise Inc *w exp 06/18/201 | 6.9 | $70M | 8.8M | 7.93 | |
Amgen (AMGN) | 6.0 | $61M | 1.1M | 54.90 | |
Human Genome Sciences | 6.0 | $60M | 2.5M | 23.89 | |
Celgene Corporation | 4.3 | $43M | 728k | 59.14 | |
First Solar (FSLR) | 4.0 | $41M | 313k | 130.14 | |
United Therapeutics Corporation (UTHR) | 4.0 | $40M | 635k | 63.22 | |
MannKind Corporation | 3.6 | $37M | 4.6M | 8.06 | |
TiVo | 3.3 | $33M | 3.8M | 8.63 | |
Alcon | 3.0 | $30M | 186k | 163.40 | |
Bristol Myers Squibb (BMY) | 2.9 | $29M | 1.1M | 26.48 | |
Alexion Pharmaceuticals | 1.6 | $16M | 201k | 80.55 | |
Netflix (NFLX) | 1.5 | $15M | 88k | 175.70 | |
Sequenom | 1.5 | $15M | 1.8M | 8.03 | |
Keryx Biopharmaceuticals | 1.4 | $14M | 3.1M | 4.58 | |
Yahoo! | 1.4 | $14M | 818k | 16.63 | |
Celgene Corp right 12/31/2011 | 1.3 | $14M | 229k | 59.14 | |
Vivus | 1.3 | $13M | 1.4M | 9.37 | |
Brocade Communications Systems | 1.3 | $13M | 2.4M | 5.29 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 1.2 | $12M | 339k | 35.03 | |
Amylin Pharmaceuticals | 1.1 | $12M | 790k | 14.71 | |
Hospira | 1.0 | $10M | 182k | 55.68 | |
Financial Select Sector SPDR (XLF) | 0.9 | $9.3M | 583k | 15.95 | |
Adobe Systems Incorporated (ADBE) | 0.9 | $9.0M | 292k | 30.78 | |
Delcath Systems | 0.9 | $9.0M | 918k | 9.80 | |
Savient Pharmaceuticals | 0.8 | $8.1M | 725k | 11.14 | |
Salix Pharmaceuticals | 0.8 | $7.9M | 168k | 46.96 | |
Orexigen Therapeutics | 0.8 | $7.7M | 948k | 8.08 | |
MercadoLibre (MELI) | 0.7 | $7.3M | 110k | 66.64 | |
Regeneron Pharmaceuticals (REGN) | 0.7 | $7.2M | 220k | 32.83 | |
Medtronic | 0.7 | $7.2M | 193k | 37.09 | |
JPMorgan Chase & Co. (JPM) | 0.7 | $6.8M | 160k | 42.42 | |
Ariad Pharmaceuticals | 0.6 | $6.5M | 1.3M | 5.10 | |
Elan Corporation | 0.6 | $5.8M | 1.0M | 5.74 | |
Amarin Corporation (AMRN) | 0.5 | $5.2M | 631k | 8.20 | |
Cubist Pharmaceuticals | 0.5 | $5.0M | 233k | 21.40 | |
BioCryst Pharmaceuticals (BCRX) | 0.4 | $4.5M | 862k | 5.17 | |
Valeant Pharmaceuticals Int | 0.4 | $4.5M | 157k | 28.29 | |
Digital River | 0.4 | $4.3M | 124k | 34.42 | |
ISIS Pharmaceuticals | 0.4 | $4.1M | 406k | 10.12 | |
Citi | 0.4 | $4.0M | 844k | 4.73 | |
NPS Pharmaceuticals | 0.4 | $4.0M | 506k | 7.90 | |
BioMimetic Therapeutics | 0.4 | $3.9M | 309k | 12.71 | |
Arena Pharmaceuticals | 0.3 | $3.5M | 2.0M | 1.73 | |
Incyte Corporation (INCY) | 0.3 | $2.9M | 177k | 16.56 | |
Inspire Pharmaceuticals | 0.3 | $2.6M | 307k | 8.40 | |
Ford Motor Company (F) | 0.2 | $2.5M | 150k | 16.79 | |
Immucor | 0.2 | $2.5M | 128k | 19.83 | |
Edwards Lifesciences (EW) | 0.2 | $2.3M | 29k | 80.84 | |
Myriad Genetics (MYGN) | 0.2 | $2.3M | 100k | 22.84 | |
Biodel | 0.2 | $2.2M | 1.2M | 1.83 | |
Medivation | 0.2 | $1.7M | 115k | 15.17 | |
AVANIR Pharmaceuticals | 0.2 | $1.7M | 424k | 4.08 | |
NuVasive | 0.2 | $1.6M | 63k | 25.65 | |
XenoPort | 0.1 | $1.3M | 149k | 8.52 | |
Protalix BioTherapeutics | 0.1 | $967k | 97k | 9.98 | |
Immunomedics | 0.1 | $941k | 263k | 3.58 | |
Chelsea Therapeutics International | 0.1 | $788k | 105k | 7.50 | |
Geron Corporation (GERN) | 0.1 | $730k | 140k | 5.20 | |
Pharmacyclics | 0.1 | $754k | 124k | 6.08 | |
Optimer Pharmaceuticals | 0.1 | $695k | 61k | 11.32 | |
AMAG Pharmaceuticals | 0.1 | $597k | 33k | 18.09 | |
InterDigital (IDCC) | 0.1 | $468k | 11k | 41.60 | |
Vical Incorporated | 0.0 | $432k | 214k | 2.02 | |
Allos Therapeutics | 0.0 | $176k | 38k | 4.61 | |
Kendle International | 0.0 | $245k | 23k | 10.89 | |
Targacept | 0.0 | $201k | 7.6k | 26.45 | |
Dell | 0.0 | $136k | 10k | 13.60 | |
Poniard Pharmaceuticals (PARD) | 0.0 | $104k | 200k | 0.52 | |
Hansen Medical | 0.0 | $144k | 97k | 1.49 | |
MELA Sciences | 0.0 | $4.7M | 1.7M | 2.75 |